Industry News
Apollo signs $500,000 deal with Symansis
Includes the sale of assets and licensing of proprietary techniques [ + ]
ChemGenex acquires leukaemia drug outright
Large stock trade to take place of royalty payments [ + ]
Court approves pSvida re-incorporation
Re-lists on NASDAQ, temporary halt on ASX [ + ]
Director of Resmed board resigns
Farrell to continue as executive director [ + ]
Pharmaust finds buyer for CBI
Terms to be voted on in July [ + ]
pSvida to list on Nasdaq
Shareholders agree to re-incorporation on US stock exchange [ + ]
Clinical Cell Culture renames
C3 changes name to Avita Medical [ + ]
BIO 2008: Australia goes to BIO
Exhibitors on the Australian Pavilion at BIO 2008 in San Diego [ + ]
BIO 2008: QTCN goes to BIO
Exhibitors on the QTCN booth at BIO 2008 in San Diego [ + ]
Benitec in the clinic
Early results from RNAi trial promising [ + ]
BIO 2008: Waking up to sleeping sickness
WA company Epichem and the Drugs for Neglected Diseases initiative are collaborating to develop new drugs to treat African sleeping sickness and similar, forgotten diseases. [ + ]
Stem cells for heart failure
Mesoblast's sister company plans phase II trials for congestive heart failure [ + ]
LCT expands diabetes trial
LCT has doubled both the sample size and dosage for next stage of clinical tria [ + ]
Arana superhumanises CSL
Arana Therapeutics completes research project with CSL [ + ]
Anadis goes over
Anadis raises over $800,000 in SPP [ + ]
